APGE Insider Transactions — Page 2
155 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–155; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer | 2025-02-05 | Sale | 3,520.0 | $40.69 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-02-05 | Sale | 15,000.0 | $40.58 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-01-08 | Sale | 2,868.0 | $49.38 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-01-08 | Sale | 12,132.0 | $48.72 |
| Dambkowski Carl | Chief Medical Officer | 2025-01-02 | Sale | 100.0 | $47.92 |
| Dambkowski Carl | Chief Medical Officer | 2025-01-02 | Sale | 2,486.0 | $47.21 |
| Dambkowski Carl | Chief Medical Officer | 2025-01-02 | Sale | 1,499.0 | $46.42 |
| McKenna Mark C. | Director | 2024-12-12 | Purchase | 12,500.0 | $49.85 |
| McKenna Mark C. | Director | 2024-12-12 | Purchase | 7,500.0 | $49.02 |
| Dambkowski Carl | Chief Medical Officer | 2024-12-11 | Sale | 455.0 | $50.0 |
| Dambkowski Carl | Chief Medical Officer | 2024-12-11 | Sale | 4,085.0 | $48.62 |
| Dambkowski Carl | Chief Medical Officer | 2024-12-04 | Sale | 6,665.0 | $46.07 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-12-04 | Sale | 1,672.0 | $47.19 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-12-04 | Sale | 13,328.0 | $46.5 |
| Dambkowski Carl | Chief Medical Officer | 2024-11-06 | Sale | 1,339.0 | $59.96 |
| Dambkowski Carl | Chief Medical Officer | 2024-11-06 | Sale | 5,326.0 | $58.91 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-11-06 | Sale | 1,000.0 | $59.94 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-11-06 | Sale | 14,000.0 | $59.17 |
| Dambkowski Carl | Chief Medical Officer | 2024-10-02 | Sale | 925.0 | $56.86 |
| Dambkowski Carl | Chief Medical Officer | 2024-10-02 | Sale | 5,740.0 | $56.16 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-10-02 | Sale | 9,712.0 | $56.74 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-10-02 | Sale | 30,288.0 | $56.07 |
| Dambkowski Carl | Chief Medical Officer | 2024-09-04 | Sale | 787.0 | $48.06 |
| Dambkowski Carl | Chief Medical Officer | 2024-09-04 | Sale | 5,878.0 | $47.49 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-09-04 | Sale | 14,359.0 | $48.23 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-09-04 | Sale | 25,641.0 | $47.28 |
| Henderson Jane | Chief Financial Officer | 2024-08-23 | Sale | 6,000.0 | $48.26 |
| Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sale | 670.0 | $42.56 |
| Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sale | 142.0 | $41.09 |
| Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sale | 6,523.0 | $40.47 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-08-07 | Sale | 100.0 | $42.17 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-08-07 | Sale | 7,667.0 | $41.52 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-08-07 | Sale | 32,233.0 | $40.4 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-07-05 | Sale | 15,000.0 | $37.26 |
| Dambkowski Carl | Chief Medical Officer | 2024-07-03 | Sale | 2,143.0 | $38.16 |
| Dambkowski Carl | Chief Medical Officer | 2024-07-03 | Sale | 3,852.0 | $37.29 |
| Shah Nimish P | Director | 2023-07-13 | Purchase | 1,750,000.0 | $17.0 |
| Harwin Peter Evan | Director | 2023-07-13 | Purchase | 892,529.0 | $17.0 |
| Fairmount Healthcare Fund L.P. | Director | 2023-07-13 | Purchase | 892,529.0 | $17.0 |
| Fairmount Healthcare Fund II L.P. | Director | 2023-07-13 | Purchase | 892,529.0 | $17.0 |
| Fairmount Funds Management LLC | Director | 2023-07-13 | Purchase | 892,529.0 | $17.0 |
| Kiselak Tomas | Director | 2023-07-13 | Purchase | 892,529.0 | $17.0 |
| Fairmount Healthcare Co-Invest II L.P. | Director | 2023-07-13 | Purchase | 892,529.0 | $17.0 |
| Harwin Peter Evan | Director | 2023-07-13 | Purchase | 1,992,734.0 | $17.0 |
| Fairmount Healthcare Fund L.P. | Director | 2023-07-13 | Purchase | 1,992,734.0 | $17.0 |
| Fairmount Healthcare Fund II L.P. | Director | 2023-07-13 | Purchase | 1,992,734.0 | $17.0 |
| Fairmount Funds Management LLC | Director | 2023-07-13 | Purchase | 1,992,734.0 | $17.0 |
| Kiselak Tomas | Director | 2023-07-13 | Purchase | 1,992,734.0 | $17.0 |
| Fairmount Healthcare Co-Invest II L.P. | Director | 2023-07-13 | Purchase | 1,992,734.0 | $17.0 |
| Harwin Peter Evan | Director | 2023-07-13 | Purchase | 55,913.0 | $17.0 |
| Fairmount Healthcare Fund L.P. | Director | 2023-07-13 | Purchase | 55,913.0 | $17.0 |
| Fairmount Healthcare Fund II L.P. | Director | 2023-07-13 | Purchase | 55,913.0 | $17.0 |
| Fairmount Funds Management LLC | Director | 2023-07-13 | Purchase | 55,913.0 | $17.0 |
| Kiselak Tomas | Director | 2023-07-13 | Purchase | 55,913.0 | $17.0 |
| Fairmount Healthcare Co-Invest II L.P. | Director | 2023-07-13 | Purchase | 55,913.0 | $17.0 |